FDA approves first generic competitor to Epipen

Main News
vlcsnap-2018-08-16-14h16m44s018_1534443413446_52097368_ver1.0_640_360_1534450243129.jpg

WASHINGTON (WCMH) – The Food and Drug Administration has approved the first generic competitor to the Epipen.

The epinephrine auto-injector is used in an emergency, when a person has a severe allergic reaction to things like food or insect stings.

Mylan, the company that sells the Epipen, drew intense criticism a few years ago when it increased the price of an Epipen twin-pack to $600. Mylan does offer its own generic version for about half the price.

A new generic from Teva pharmaceuticals could drive the price down even further.

Other generic epinephrine auto-injectors exist but need to be specifically prescribed.

Parents and those involved in raising awareness for allergies say this kind of competition in the market is long overdue.

“When we go to buy shirts or shoes or cars or any kind of thing in the grocery store we have so many choices from so many different brands and I think to bring down these barriers to entry so that American families can have affordable choice in this particular product category is going to be what saves lives,” said Robyn O’Brien, a food allergy awareness advocate.

The price of the new generic has not been announced. It will be available in the coming months.

Copyright 2019 Nexstar Broadcasting, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Don't Miss

More Don't Miss

KRBC News